Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Jul 2013

Peters Solange, Michielin Olivier, Zimmermann Stefan

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Needle
Share to Chemotherapy, Adjuvant
Share to Combined Modality Therapy
Share to Multimodal Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pneumonectomy

Share to Positron-Emission Tomography

Share to Radiotherapy, Adjuvant

Share to Vemurafenib

Source

Identifiers

PMID: 23733758
DOI: 10.1200/JCO.2012.47.6143

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma.PMID 23733758Read ↗

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.Semantic proximity Read ↗

A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation.Semantic proximity Read ↗

A patient with malignant pleural mesothelioma carrying BRAF V600E mutation responding to vemurafenib.Semantic proximity Read ↗

BRAFV600 mutant non-small-cell lung cancer resistant to Vemurafenib.Semantic proximity Read ↗

Vemurafenib.Semantic proximity Read ↗

Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAFV600E-mutant metastatic melanoma.Semantic proximity Read ↗

The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma.Semantic proximity Read ↗

Impressive Response to Tyrosine Kinase Inhibitors in a Patient with Respiratory Failure for EGFR-Mutated Metastatic Lung Cancer.Semantic proximity Read ↗

Lung Adenocarcinoma Harboring Concomitant EGFR Mutations and BRAF V600E Responds to a Combination of Osimertinib and Vemurafenib to Overcome Osimertinib Resistance.Semantic proximity Read ↗

BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib.Semantic proximity Read ↗

FDA approves vemurafenib for treatment of metastatic melanoma.Semantic proximity Read ↗

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.